Search
Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation (Last Updated: Aug 1, 2023)
Hearing Aids and Dementia (Last Updated: Jul 6, 2023)
An Overview of Pharmacogenomic Testing for Psychiatric Disorders (Last Updated: Jun 6, 2023)
Pharmacogenomic testing is a precision medicine technology that examines genetic variation in medication metabolism. Selected for inclusion in the Canada's Drug Agency 2023 Watch List, pharmacogenomic...
Occupational Therapy for Mental Health Conditions and Substance Use Disorders (Last Updated: Apr 27, 2023)
Considerations of Access and Inclusion in Adolescent Eating Disorder Care: A Custom Rapid Report (Last Updated: Apr 20, 2023)
Nabilone for the Treatment of Post-Traumatic Stress Disorder: A 2023 Update (Last Updated: Feb 24, 2023)
Evaluating Peer Support Programs for Youth Mental Health — Summary of an Environmental Scan (Last Updated: Nov 17, 2022)
Canada's Drug Agency conducted a Health Technology Assessment to support decisions related to the implementation and evaluation of formal peer support programs for youth mental health. This summary...
In Brief: Peer Support Programs for Youth Mental Health (Last Updated: Nov 10, 2022)
Key Messages We conducted a Health Technology Assessment (HTA) to inform decisions related to the adoption, implementation, and evaluation of peer support programs for youth mental health. The main...
Peer Support Programs for Youth Mental Health (Last Updated: Nov 8, 2022)
Canada's Drug Agency assessed the clinical effectiveness and safety of formal peer support programs for youth mental health to support decision-making about adopting, implementing, and evaluating...